| AP2A2 Protein | |
|---|---|
| Protein Name | AP-2 Complex Subunit Alpha 2 |
| Gene | AP2A2 |
| UniProt ID | O95773 |
| Molecular Weight | ~104 kDa |
| Subcellular Localization | Clathrin-coated vesicles, plasma membrane |
| Protein Family | Adaptor protein complex family |
AP2A2 (AP-2 Complex Subunit Alpha 2) is a critical component of the clathrin adaptor protein complex 2 (AP-2), one of the major coat proteins involved in clathrin-mediated endocytosis (CME) [1]. The AP-2 complex is a heterotetramer composed of four subunits: two large chains (α and β2), one medium chain (μ2), and one small chain (σ2). AP2A2, as the α-adaptin subunit, plays essential roles in cargo recognition, clathrin coat assembly, and synaptic vesicle recycling at presynaptic terminals [2]. The protein is particularly important in the nervous system, where it facilitates the rapid recycling of synaptic vesicles and the internalization of various receptors and transporters. Dysregulation of AP2A2 has been implicated in neurodegenerative diseases, particularly Alzheimer's disease, where altered endocytic trafficking contributes to amyloid-β production and pathological accumulation [3].
The AP-2 complex adopts a characteristic architecture with distinct functional domains:
Cargo Recognition: The μ2 subunit recognizes YXXΦ motifs (where Y=tyrosine, X=any amino acid, Φ=hydrophobic residue), while the α-subunit contributes to cargo selection and localization [4].
AP2A2 is central to clathrin-mediated endocytosis [5]:
Cargo Selection:
Coat Assembly:
Synaptic Vesicle Recycling:
AP2A2 participates in multiple trafficking pathways:
Receptor Internalization:
Nutrient Uptake:
Synaptic Function:
AP2A2 maintains cellular homeostasis through:
AP2A2 dysfunction significantly contributes to AD pathogenesis [6]:
Amyloid-β Production:
Amyloid Pathology:
Therapeutic Implications:
AP2A2 plays roles in PD pathogenesis [7]:
α-Synuclein Internalization:
Dopamine Transporter Regulation:
AP2A2 involvement in ALS [8]:
TDP-43 Trafficking:
Vesicle Trafficking Defects:
AP2A2 is dysregulated in various cancers [9]:
Oncogenic Signaling:
Metastasis:
| Protein | Interaction Type | Functional Significance |
|---|---|---|
| Clathrin | Structural component | Coat formation |
| β2-Adaptin | Complex subunit | Heterotetramer formation |
| μ2 (PICALM) | Complex subunit | Cargo recognition |
| Amphiphysin | BAR domain protein | Membrane curvature |
| Dynamin | GTPase | Vesicle scission |
| Synaptojanin | Phosphatase | Uncoating |
| Endophilin | BAR domain protein | Membrane remodeling |
Targeting AP2A2 and associated pathways:
Polymorphisms in AP2A2 affect disease risk: